Literature DB >> 2694521

Selective effector coupling of muscarinic acetylcholine receptor subtypes.

K Fukuda, T Kubo, A Maeda, I Akiba, H Bujo, J Nakai, M Mishina, H Higashida, E Neher, A Marty.   

Abstract

Attempts have been made by means of recombinant DNA technology to understand the molecular basis of the functional heterogeneity of the muscarinic acetylcholine receptor (mAChR). Molecularly defined mAChR subtypes have been produced from the cloned DNAs in Xenopus oocytes and NG108-15 neuroblastoma-glioma hybrid cells as transient and stable expression systems, respectively, and agonist-induced cellular responses have been examined. The results obtained provide evidence that mAChR subtypes are selectively coupled with different effector systems, albeit not exclusively.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2694521

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  4 in total

1.  Regulation of bladder muscarinic receptor subtypes by experimental pathologies.

Authors:  M R Ruggieri; A S Braverman
Journal:  Auton Autacoid Pharmacol       Date:  2006-07

2.  Muscarinic acetylcholine receptor subtypes mediating urinary bladder contractility and coupling to GTP binding proteins.

Authors:  P Wang; G R Luthin; M R Ruggieri
Journal:  J Pharmacol Exp Ther       Date:  1995-05       Impact factor: 4.030

3.  Inositol 1,4,5-trisphosphate formation and ryanodine-sensitive oscillations of cytosolic free Ca2+ concentrations in neuroblastoma x fibroblast hybrid NL308 cells expressing m2 and m4 muscarinic acetylcholine receptor subtypes.

Authors:  N Ishizaka; M Noda; Y Kimura; M Hashii; K Fukuda; M Katayama; D A Brown; H Higashida
Journal:  Pflugers Arch       Date:  1995-01       Impact factor: 3.657

4.  Molecular dissection of functional domains of the E1E2-ATPase using sodium and calcium pump chimeric molecules.

Authors:  D B Luckie; V Lemas; K L Boyd; D M Fambrough; K Takeyasu
Journal:  Biophys J       Date:  1992-04       Impact factor: 4.033

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.